Percutaneous and Transdermal Oestrogen Replacement Therapy

References

• Scheuplein R J., Blank I H., Brauner G J., Macfarlane D J. Percutaneous absorption of steroids. J Invest Derm 1969; 52: 63–70
   PubMed Web of Science ®Google Scholar
• Vickers C FH. Reservoir effect of human skin: pharmacological speculation. Percutaneous absorption of steroids., P Mauvais-Jarvis, C FH Vickers, J Wepierre. Academic Press, London 1980; 19–29
   Google Scholar
• Scheuplein R J. Percutaneous absorption: theoretical aspects. Percutaneous absorption of steroids., P Mauvais-Jarvis, C FH Vickers, J Wepierre. Academic Press, London 1980; 1–17
   Google Scholar
• Marty J P., James M, Hajo N, Wepierre J. Percutaneous absorption of oestradiol and progesterone: pharmacokinetic studies. Percutaneous absorption of steroids., P Mauvais-Jarvis, C FH Vickers, J Wepierre. Academic Press, London 1980; 205–18
   Google Scholar
• Chien Y W. Development of transdermal drug delivery systems. Drug Dev Indust Pharm 1987; 13: 589–651
   Web of Science ®Google Scholar
• Wendker H, Schaefer H. Penetration kinetics and distribution of topically applied estrogens. Archs Dermatol Res 1976; 256: 67–9
   PubMedGoogle Scholar
• Feldmann R J., Maibach H I. Percutaneous penetration of steroids in man. J Invest Derm 1969; 52: 89–94
   PubMed Web of Science ®Google Scholar
• Basdevant A, De Llgnières B. Treatment of menopause by topical administration of estradiol. Percutaneous absorption of steroids., P Mauvais-Jarvis, C FH Vickers, J Wepierre. Academic Press, London 1980; 249–58
   Google Scholar
• Sltruk-Ware R, De Lignlères B, Basdevant A, Mauvais-Jarvis P. Absorption of percutaneous oestradiol in postmenopausal women. Maturitas 1980; 2: 207–11
   PubMedGoogle Scholar
• De Lignlères B, Vincens M. Differential effects of exogenous oestradiol and progesterone on mood in postmenopausal women: individual dose/effect relationship. Maturitas 1982; 4: 67–72
   PubMedGoogle Scholar
• Elkik F, Gompel A, Mercier-Bodard C, et al. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol 1982; 143: 888–92
   PubMed Web of Science ®Google Scholar
• Utian W H., Katz M, Davey D A., Carr P J. Effect of premenopausal castration and incremental dosages of conjugated equine estrogens on plasma follicle-stimulating hormone, luteinizing hormone and estradiol. Am J Obstet Gynec 1978; 132: 297–302
   PubMed Web of Science ®Google Scholar
• Chien Y W. Development of transdermal controlled-release drug delivery systems. Transdermal Delivery of drugs, Berner Kydonieus. CRC Press, Boca Raton 1987; 1: 81–100
   Google Scholar
• Powers M S., Schenkel L, Darley P E., Good W R., Balestra J C., Place V A. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 β-estradiol. Comparison with conventional oral estrogen used for hormone replacement. Am J Obstet Gynecol 1985; 152: 1099–106
   PubMed Web of Science ®Google Scholar
• Laufer L R., DeFazio J L., Lu J KH, et al. Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynec 1983; 146: 533–40
   PubMed Web of Science ®Google Scholar
• Balfour J A., Heel R C. Transdermal estradiol. A review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of menopausal complaints. Drugs 1990; 40: 561–82
   PubMed Web of Science ®Google Scholar
• Whitehead Ml, Townsend P T., Van den Ryder T A., King R JB. Effects of oestrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981; 305: 1599–605
   PubMed Web of Science ®Google Scholar
• Whitehead Ml, Padwick M L., Endacott J, Pryse-Davies J. Endometrial responses to transdermal estradiol in postmenopausal women. Am J Obstet Gynecol 1985; 152: 1079–84
   PubMedGoogle Scholar
• Utian W H. Transdermal estradiol overall safety profile. Am J Obstet Gynecol 1987; 156: 1335–8
   PubMed Web of Science ®Google Scholar
• Whitehead Ml, Siddle N, Lane G, . The pharmacology of progestogens. The menopause., D Mishell, Jr, et al. Year Book, Chicago 1987; 317–34
   Google Scholar
• Clisham P, Judd H, Fu Y, Lozano K, Cedars M. Bleeding patterns and endometrial histology with long-term transdermal estradiol therapy. Fertil Steril 1988; S24–5, Suppl: Abstract 070
   Google Scholar
• Feldberg W, Hellon R F., Lotti V J. Temperature effects produced in dogs and monkeys by injections of monoamines and related substances into the third ventricle. J Physiol (Lond) 1967; 191: 501–15
   Google Scholar
• Steingold K A., Laufer L, Chetkowski R J., et al. Treatment of hot flushes with transdermal estradiol administration. J Clin Endocr Metab 1985; 61: 627–32
   PubMed Web of Science ®Google Scholar
• Padwick M L., Endacott J, Whitehead Ml. Efficacy, acceptability and metabolic effects of transdermal estradiol in the management of postmenopausal women. Am J Obstet Gynecol 1985; 152: 1085–91
   PubMed Web of Science ®Google Scholar
• Gangar K F., Vyas S, Van den Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal estradiol and time since menopause. Lancet 1991; 338: 839–42
   PubMed Web of Science ®Google Scholar
• Bourne T, Hillard T C., Van den Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancef 1990; 335: 1470–1
   PubMed Web of Science ®Google Scholar
• De Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 1991; 55: 775–9
   PubMed Web of Science ®Google Scholar
• Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind controlled clinical study. N Engl J Med 1987; 316: 173–7
   PubMed Web of Science ®Google Scholar
• Ribot C, Trémollières F, Pouillès J M., Louvet J P., Peyron R. Preventive effects of transdermal administration of 17β-estradiol on postmenopausal bone loss: A 2-year prospective study. Obstet Gynecol 1990; 75(Suppl)43S–6S
   Google Scholar
• Adami S, Suppi R, Bertoldo F, et al. Transdermal estradiol in the treatment of postmenopausal bone loss. Bone and Mineral 1989; 7: 79–86
   PubMedGoogle Scholar
• Field C S., Ory S J., Wahner H W., Herrmann R R., Judd H L., Riggs B L. Preventive effects of transdermal 17 β-estradiol on osteoporotic changes after surgical menopause: A 2-year placebo-controlled trial. Am J Obstet Gynecol 1992
   Google Scholar
• Lufkin E G., Wahner H W., O'Fallon W M., et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Int Med 1992; 117: 1–9
   PubMed Web of Science ®Google Scholar
• De Llgnières B, Basdevant A, Thomas G, et al. Biological effects of estradiol-17 β in postmenopausal women: oral versus percutaneous administration. J Clin Endocr Metab 1986; 62: 536–41
   PubMedGoogle Scholar
• Chetkowski R J., Meldrum D R., Steingold K A., et al. Biologic effects of transdermal estradiol. N Engl J Med 1987; 314: 1615–20
   Google Scholar
• Jensen J, Riis B J., Strom V, Nilas L, Christiansen C. Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 1987; 156: 66–71
   PubMed Web of Science ®Google Scholar
• Lobo R A., March C M., Goebelsmann U, Krauss R M., Mishell D R., Jr. Subdermal estradiol pellets following hysterectomy and oophorectomy. Am J Obstet Gynecol 1980; 138: 714–9
   PubMedGoogle Scholar
• Whitehead Ml, Fraser D. Controversies concerning the safety of estrogen replacement therapy. Am J Obstet Gynecol 1987; 156: 1313–22
   PubMed Web of Science ®Google Scholar
• Sharf M, Oettinger M, Lanir A, Kahana L, Yeshurun D. Lipid and lipoprotein levels following pure estradiol implantation in post-menopausal women. Gynecol Obstet Invest 1985; 19: 207–12
   PubMedGoogle Scholar
• Stanczyk F Z., Shoupe D, Nunez V, Macias-Gonzales P, Vijod M A., Lobo A. A randomized comparison of non oral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 1988; 159: 1540–6
   PubMed Web of Science ®Google Scholar
• Samsioe G. Lipid metabolic effects of transdermal estradiol. Sixth International Congress on the Menopause, Bangkok, 1990, Abstract
   Google Scholar
• Bush T L., Barrett-Connor E, Cowan L D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 1987; 75: 1102–9
   PubMed Web of Science ®Google Scholar
• Adams M R., Kaplan J R., Manuck S B., et al. Inhibition of coronary artery atherosclerosis by 17beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990; 10: 1051–7
   PubMedGoogle Scholar
• McEwen B S. Gonadal steroid receptors in neuroendocrine tissues. Receptors and hormone action, B W. O'Maliey, L Birnbaumer. Academic Press, London 1978; 353–400
   Google Scholar
• Utian W H. The true clinical features of postmenopause and oophorectomy and their response to oestrogen therapy. South Afric Med J 1972; 46: 732–7
   PubMed Web of Science ®Google Scholar
• Wiklund I, Hoist J, Karlberg J, et al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 1992; 14: 211–24
   PubMed Web of Science ®Google Scholar
• Davis G F., Winter L. Cumulative irritation study of placebo transdermal estrogen patches. Curr Ther Res 1987; 42: 712–9
   Google Scholar